Mercedes
Iñarrairaegui Bastarrica

Consultora Médica

Foto de Mercedes

Foto de Universitat Autònoma de Barcelona

Universitat Autònoma de Barcelona

Barcelona, España

Publications in collaboration with researchers from Universitat Autònoma de Barcelona (4)

2021

Corrigendum to “Time association between hepatitis C therapy and hepatocellular carcinoma emergence in cirrhosis: Relevance of non-characterized nodules” [J Hepatol (2019) 874–884] (Journal of Hepatology (2019) 70(5) (874–884), (S0168827819300157), (10.1016/j.jhep.2019.01.005))
Journal of Hepatology

2019

Effectiveness and safety of sofosbuvir/velpatasvir/voxilaprevir in patients with chronic hepatitis C previously treated with DAAs
Journal of Hepatology, Vol. 71, Núm. 4, pp. 666-672
Time association between hepatitis C therapy and hepatocellular carcinoma emergence in cirrhosis: Relevance of non-characterized nodules
Journal of Hepatology, Vol. 70, Núm. 5, pp. 874-884

2017

Clinical characteristics of hepatocellular carcinoma in Spain. Comparison with the 2008-2009 period and analysis of the causes of diagnosis out of screening programs. Analysis of 686 cases in 73 centers
Medicina Clinica, Vol. 149, Núm. 2, pp. 61-71